Abstract
Purpose
Understanding secular trends of thyroid cancer is critical to plan strategies for cancer prevention and control. Our aim was to estimate the incidence and mortality trends of thyroid cancer in China during 2005–2015.
Methods
A retrospective cohort evaluation of thyroid cancer cases and deaths during 2005–2015 was performed using population-based data from the Chinese Cancer Registry Annual Report. The incidence and mortality rates of thyroid cancer were stratified by gender, age group (0, 1–4, 5–9, 10–14…80–84, 85–), and area (urban or rural). A Joinpoint regression model was used to examine secular trends.
Results
In China, the age-standardized incidence was 3.21/105 in 2005, and increased to 9.61/105 in 2015. Besides, a significant increase incidence rate was observed with the average annual percent change (AAPC) of 12.4% (95% CI: 10.5%–14.4%) in the period 2005–2015. The age-standardized mortality was 0.30/105 in 2005 and 0.35/105 in 2015, and the AAPC was 2.9% (95% CI: 1.3%–4.5%). For both incidence and mortality, the rates of thyroid cancer were much higher in females than in males, and in urban areas rather than rural areas; however, the rates of increasing trends showed no significant differences. With respect to the highest age-specific rates, it appeared in the age group of 50–54 years old for incidence and in the age group of 80–84 years old for mortality. Notably, the rate of increasing incidence trend was lower in older age groups, especially for people aged 70–79 years old.
Conclusion
A rapid increase in incidence and a moderate increase in mortality of thyroid cancer were observed from 2005 to 2015 in our study. Effective measures and tailored programs should be taken to curb the growth trend and reduce the disease burden.
Similar content being viewed by others
References
J. Ferlay, I. Soerjomataram, R. Dikshit et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J. Cancer 136(5), E359–E386 (2015)
J. He, W. Chen, Chinese Cancer Registry Annual Report. Beijing, People’s Medical Publishing House, 2017
L. Davies, H.G. Welch, Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295(18), 2164–2167 (2006)
S. Liu, R. Semenciw, A.M. Ugnat et al. Increasing thyroid cancer incidence in Canada, 1970–1996: time trends and age-period-cohort effects. Br. J. Cancer 85(9), 1335–1339 (2001)
G. Smailyte, E. Miseikyte-Kaubriene, J. Kurtinaitis, Increasing thyroid cancer incidence in Lithuania in 1978–2003. BMC Cancer 6(1), 284 (2006)
U. Jayarajah, A. Fernando, S. Prabashani et al. Incidence and histological patterns of thyroid cancer in Sri Lanka 2001–2010: an analysis of national cancer registry data. BMC Cancer 18(1), 163 (2018)
L. Du, Y. Wang, X. Sun et al. Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang province, Southeast China. BMC Cancer 18(1), 291 (2018)
J.H. Lubin, M.J. Adams, R. Shore et al. Thyroid cancer following childhood low-dose radiation exposure: a pooled analysis of nine cohorts. J. Clin. Endocrinol. Metab. 102(7), 2575–2583 (2017)
R. Rahbari, L. Zhang, E. Kebebew, Thyroid cancer gender disparity. Future Oncol. 6(11), 1771–1779 (2010)
A. Belfiore, G.L. La Rosa, G. Padova et al. The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodine-deficient area. Cancer 60(12), 3096–3102 (1987)
L. Davies, H.G. Welch, Current thyroid cancer trends in the United States. JAMA Otolaryngol. Head Neck Surg. 140(4), 317–322 (2014)
Y.M. Choi, T.Y. Kim, E.K. Jang et al. Standardized thyroid cancer mortality in Korea between 1985 and 2010. Endocrinol. Metab. 29(4), 530–535 (2014)
L. Leenhardt, M.O. Bernier, M.H. Boin-Pineau et al. Advances in diagnostic practices affect thyroid cancer incidence in France. Eur. J. Endocrinol. 150(2), 133–139 (2004)
L.G. Morris, D. Myssiorek, Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis. Am. J. Surg. 200(4), 454–461 (2010)
A.Y. Chen, A. Jemal, E.M. Ward, Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer 115(16), 3801–3807 (2009)
H.J. Kim, M.P. Fay, E.J. Feuer et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat. Med. 19(3), 335–351 (2000)
K.W. Jung, Y.J. Won, H.J. Kong et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2015. Cancer Res. Treat. 50(2), 303–316 (2018)
E. Salamanca-Fernandez, M. Rodriguez-Barranco, Y.L. Chang-Chan et al. Thyroid cancer epidemiology in South Spain: a population-based time trend study. Endocrine 62(2), 423–431 (2018)
H. Lim, S.S. Devesa, J.A. Sosa et al. Trends in thyroid cancer incidence and mortality in the United States, 1974–2013. JAMA 317(13), 1338–1348 (2017)
Y.M. Choi, W.G. Kim, H. Kwon et al. Changes in standardized mortality rates from thyroid cancer in Korea between 1985 and 2015: analysis of Korean national data. Cancer 123(24), 4808–4814 (2017)
C. La Vecchia, M. Malvezzi, C. Bosetti et al. Thyroid cancer mortality and incidence: a global overview. Int J. Cancer 136(9), 2187–2195 (2015)
L. Du, R. Li, M. Ge et al. Incidence and mortality of thyroid cancer in China, 2008–2012. Chin. J. Cancer Res. 31(1), 144–151 (2019)
M.M. Fidler, S. Gupta, I. Soerjomataram et al. Cancer incidence and mortality among young adults aged 20–39 years worldwide in 2012: a population-based study. Lancet Oncol. 18(12), 1579–1589 (2017)
W. Chen, C. Xia, R. Zheng et al. Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment. Lancet Glob. Health 7(2), e257–e269 (2019)
K. Song, L. Du, H. Li et al. Incidence and mortality of thyroid cancer in six cancer registries of Zhejiang province, 2000–2009. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 49(6), 493–496 (2014)
S. Grodski, T. Brown, S. Sidhu et al. Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery 144(6), 1038–1043 (2008)
L. Leenhardt, P. Grosclaude, L. Cherie-Challine, Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects? Report from the French thyroid cancer committee. Thyroid 14(12), 1056–1060 (2004)
M.P. Curade, B. Edwards, H.R. Shin et al. Cancer incidence in five continents. Lyon: IARC scientific publications, IX, 1–837 (2008)
L. Zabuliene, D. Jasilionis, E. Miseikyte-Kaubriene et al. Parity and risk of thyroid cancer: a population-based study in Lithuania. Horm. Cancer 8(5–6), 325–329 (2017)
M. Zane, C. Parello, G. Pennelli et al. Estrogen and thyroid cancer is a stem affair: a preliminary study. Biomed. Pharmacother. 85, 399–411 (2017)
B. Sinnott, E. Ron, A.B. Schneider, Exposing the thyroid to radiation: a review of its current extent, risks, and implications. Endocr. Rev. 31(5), 756–773 (2010)
P. Jacob, T.I. Bogdanova, E. Buglova et al. Thyroid cancer among Ukrainians and Belarusians who were children or adolescents at the time of the Chernobyl accident. J. Radio. Prot. 26(1), 51–67 (2006)
M. Imaizumi, W. Ohishi, E. Nakashima et al. Association of radiation dose with prevalence of thyroid nodules among atomic bomb survivors exposed in childhood (2007–2011). JAMA Intern. Med. 175(2), 228–236 (2015)
T.H. Wu, W.C. Lin, W.K. Chen et al. Predicting cancer risks from dental computed tomography. J. Dent. Res. 94(1), 27–35 (2015)
A.J. Bauer, G.L. Francis, Evaluation and management of thyroid nodules in children. Curr. Opin. Pediatr. 28(4), 536–544 (2016)
P. Laurberg, P.I. Bulow, N. Knudsen et al. Environmental iodine intake affects the type of nonmalignant thyroid disease. Thyroid 11(5), 457–469 (2001)
M. Knobel, G. Medeiros-Neto, Relevance of iodine intake as a reputed predisposing factor for thyroid cancer. Arq. Bras. Endocrinol. Metab. 51(5), 701–712 (2007)
J. Kanno, H. Onodera, K. Furuta et al. Tumor-promoting effects of both iodine deficiency and iodine excess in the rat thyroid. Toxicol. Pathol. 20(2), 226–235 (1992)
C.M. Kitahara, M. Gamborg, D.G.A. Berrington et al. Childhood height and body mass index were associated with risk of adult thyroid cancer in a large cohort study. Cancer Res. 74(1), 235–242 (2014)
M.F. Leitzmann, A. Brenner, S.C. Moore et al. Prospective study of body mass index, physical activity and thyroid cancer. Int. J. Cancer 126(12), 2947–2956 (2010)
F. Clavel-Chapelon, G. Guillas, L. Tondeur et al. Risk of differentiated thyroid cancer in relation to adult weight, height and body shape over life: the French E3N cohort. Int J. Cancer 126(12), 2984–2990 (2010)
B. Ma, H. Jiang, D. Wen et al. Transcriptome analyses identify a metabolic gene signature indicative of dedifferentiation of papillary thyroid cancer. J. Clin. Endocrinol. Metab. 104(9), 3713–3725 (2019)
Y. Hwang, K.E. Lee, E. Weiderpass et al. Acute high-dose and chronic lifetime exposure to alcohol consumption and differentiated thyroid cancer: T-CALOS Korea. PLoS ONE 11(3), e151562 (2016)
X. Wang, W. Cheng, J. Li et al. A meta-analysis of alcohol consumption and thyroid cancer risk. Oncotarget 7(34), 55912–55923 (2016)
E. Peterson, P. De, R. Nuttall, BMI, diet and female reproductive factors as risks for thyroid cancer: a systematic review. PLoS ONE 7(1), e29177 (2012)
C.L. Meinhold, E. Ron, S.J. Schonfeld et al. Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study. Am. J. Epidemiol. 171(2), 242–252 (2010)
M.A. Rossing, K.L. Cushing, L.F. Voigt et al. Risk of papillary thyroid cancer in women in relation to smoking and alcohol consumption. Epidemiology 11(1), 49–54 (2000)
J. Kim, J.E. Gosnell, S.A. Roman, Geographic influences in the global rise of thyroid cancer. Nat. Rev. Endocrinol. 16(1), 17–29 (2020)
Acknowledgements
This study was supported by the National Natural Science Foundation of China (NO. 81001280, 81202277), Cultivating Grand for Youth Key Teacher in Higher Education Institutions of Henan province (NO. 2017GGJS012) and Natural Science Fund of Henan Province (NO. 182300410303).
Author contributions
LL and ZP conceived and designed the study. JW and YS analyzed the data. JW, FY and LL interpreted the data. JW drafted the manuscript. All authors reviewed and approved the final version manuscript. JW and ZP had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human or participants or animals performed by any of the authors.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Wang, J., Yu, F., Shang, Y. et al. Thyroid cancer: incidence and mortality trends in China, 2005–2015. Endocrine 68, 163–173 (2020). https://doi.org/10.1007/s12020-020-02207-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-020-02207-6